Aripiprazole: all 299 studies that test it

Page 1 of 3. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.

• The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adults With Treatment Resistant Depression.Not yet recruitingNCT07810738Phase 2
• Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)Not yet recruitingNCT07714213Phase 2
• Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic MedicationsRecruitingNCT07565428Phase 3
• Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.Not yet recruitingNCT07547384Not applicable
• Cerebellum-based Imaging Neural Markers for Antipsychotic ResponseRecruitingNCT07483294Phase 4
• Dopamine and Sensorimotor Function in StutteringRecruitingNCT07215884Phase 1
• Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent Depression（SMART-I)Not yet recruitingNCT07011693Phase 4
• Biomarkers to Enhance Early Schizophrenia TreatmentRecruitingNCT06969755Phase 4
• Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology AnalysisNot yet recruitingNCT06060886Phase 4
• EFFECT OF RISPERIDONE vs ARIPIPRAZOLE ON OXIDATIVE STRESS IN PATIENTS WITH AUTISM SPECTRUM DISORDER: A RANDOMIZED CONTROLLED TRIALNot yet recruitingNCT05868720Not applicable
• Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)RecruitingNCT05814640Phase 1/2
• Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCTNot yet recruitingNCT05766540Phase 4
• Aripiprazole in Body Focused Repetitive BehaviorsNot yet recruitingNCT05545891Phase 2
• Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on AnhedoniaRecruitingNCT05389046Not applicable
• A Trial to Assess a Wearable Patch's Functioning to Detect Medication IngestionCompletedNCT06372210Not applicableResults posted
• C-Cog in Early Course Schizophrenia StudyTerminatedNCT05662306Phase 4Results posted
• Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia EpisodeTerminatedNCT04203056Phase 4Results posted
• A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 DisorderCompletedNCT04030143Phase 1/2Results posted
• A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®TerminatedNCT03892889Phase 3Results posted
• Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's DisorderTerminatedNCT03661983Phase 4Results posted
• A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical AntipsychoticCompletedNCT03568500Phase 4Results posted
• CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)CompletedNCT03408873Phase 4Results posted
• A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of SchizophreniaCompletedNCT03345979Phase 3Results posted
• Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male AdultsCompletedNCT03342963Phase 1Results posted
• Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRDCompletedNCT02977299Phase 4Results posted
• Optimizing Outcomes of Treatment-Resistant Depression in Older AdultsCompletedNCT02960763Phase 4Results posted
• Aripiprazole for Bipolar Disorder and Alcohol Use DisorderCompletedNCT02918370Phase 3Results posted
• Aripiprazole, Abilify Maintena Collaborative Clinical ProtocolTerminatedNCT02717130Not applicableResults posted
• A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With SchizophreniaCompletedNCT02634320Phase 4Results posted
• Aripiprazole, Abilify Maintena Collaborative Clinical ProtocolTerminatedNCT02472652Phase 4Results posted
• A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass SpectrometryTerminatedNCT02462473Phase 2Results posted
• A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic SchizophreniaTerminatedNCT02435836Phase 3Results posted
• Fluoxetine vs Aripiprazole Comparative Trial (FACT)TerminatedNCT02357849Phase 4Results posted
• A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With SchizophreniaCompletedNCT02220712Phase 1Results posted
• Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)CompletedNCT02091882Phase 4Results posted
• Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute SchizophreniaCompletedNCT02054702Phase 3Results posted
• Aripiprazole Once-monthly in Patients With SchizophreniaCompletedNCT01959035Phase 3Results posted
• A Short Treatment Study of Aripiprazole in Pediatric Patients With SchizophreniaCompletedNCT01942161Phase 2/3Results posted
• A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With SchizophreniaCompletedNCT01942148Phase 3Results posted
• Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With SchizophreniaCompletedNCT01909466Phase 1Results posted
• An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)CompletedNCT01895452Phase 3Results posted
• A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM DepotCompletedNCT01870999Phase 1Results posted
• Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01727713Phase 3Results posted
• Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01727700Phase 3Results posted
• Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I DisorderCompletedNCT01710709Phase 3Results posted
• Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With SchizophreniaCompletedNCT01683058Phase 3Results posted
• Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With SchizophreniaCompletedNCT01663532Phase 3Results posted
• An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With SchizophreniaCompletedNCT01646827Phase 1Results posted
• A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)CompletedNCT01626456Phase 3Results posted
• A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic DisorderCompletedNCT01617460Phase 3Results posted
• A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic DisorderCompletedNCT01617447Phase 3Results posted
• Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than AripiprazoleCompletedNCT01552772Phase 1Results posted
• Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleTerminatedNCT01509053Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With SchizophreniaCompletedNCT01469039Phase 3Results posted
• Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's TypeCompletedNCT01438060Phase 3Results posted
• Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleCompletedNCT01432444Phase 3Results posted
• VA Augmentation and Switching Treatments for Improving Depression OutcomesCompletedNCT01421342Phase 3Results posted
• Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)CompletedNCT01418352Phase 3Results posted
• Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01418339Phase 3Results posted
• Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01416441Phase 3Results posted
• Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With SchizophreniaCompletedNCT01338298Not applicableResults posted
• Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)CompletedNCT01333072Phase 4Results posted
• Aripiprazole Effects on Alcohol Drinking and CravingCompletedNCT01292057Phase 3Results posted
• Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic DisorderCompletedNCT01227668Phase 4Results posted
• Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy SubjectsCompletedNCT01188668Phase 4Results posted
• Efficacy & Safety Study of Oral Aripiprazole in Adolescents With SchizophreniaCompletedNCT01149655Phase 3Results posted
• An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With SchizophreniaCompletedNCT01129882Phase 3Results posted
• To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01123707Phase 3Results posted
• Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.TerminatedNCT01122927Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111565Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111552Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111539Phase 3Results posted
• FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum DisordersCompletedNCT01028820Phase 4Results posted
• Oral Aripiprazole Open-Label Rollover StudyCompletedNCT01001702Phase 3Results posted
• Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant DepressionCompletedNCT00953745Not applicableResults posted
• Trial of Aripiprazole in TrichotillomaniaCompletedNCT00947154Not applicableResults posted
• Examining the Effects of Antipsychotic Medications on Insulin SensitivityCompletedNCT00895921Phase 4Results posted
• Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY)CompletedNCT00892047Phase 4Results posted
• Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT00882362Phase 3Results posted
• Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT00876343Phase 3Results posted
• Study of Aripiprazole in the Treatment of Pervasive Developmental DisordersCompletedNCT00870727Phase 3Results posted
• Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic SyndromeTerminatedNCT00857818Phase 3Results posted
• Comparison of Optimal Antipsychotic Treatments for Adults With SchizophreniaCompletedNCT00802100Phase 4Results posted
• Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar DisorderTerminatedNCT00746252Not applicableResults posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00731549Phase 3Results posted
• Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in SchizophreniaTerminatedNCT00712270Phase 4Results posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00706654Phase 3Results posted
• Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's DisorderCompletedNCT00706589Phase 3Results posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00705783Phase 3Results posted
• A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant TherapyCompletedNCT00683852Phase 3Results posted
• An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol DependenceCompletedNCT00667875Phase 2Results posted
• Study of Aripiprazole to Reduce Medical Risks in Bipolar DisorderTerminatedNCT00665444Not applicableResults posted
• Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I DisorderCompletedNCT00665366Phase 3Results posted
• Study of Aripiprazole to Treat Children and Adolescents With AutismCompletedNCT00619190Phase 2Results posted
• Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory DepressionCompletedNCT00608543Phase 4Results posted
• A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed EpisodeCompletedNCT00606320Phase 3Results posted
• A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed EpisodeCompletedNCT00606281Phase 3Results posted
• A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed EpisodeCompletedNCT00606229Phase 3Results posted
• A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed EpisodeCompletedNCT00606177Phase 3Results posted
• The Combination of Aripiprazole and Antidepressants in Psychotic Major DepressionCompletedNCT00556140Phase 3Results posted

← Aripiprazole overview